Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome

L Lisa A. De Stefano H Hyeonseok Kim (Wearable Intelligent Systems and Healthcare Center, Institute for Matter and Systems, Georgia Institute of Technology) C Craig A. Erickson E Ernest V. Pedapati K Kelli C. Dominick R Rebecca Shaffer L Logan K. Wink L Lauren M. Schmitt M Makoto Miyakoshi

Article Details

Volume / Issue Vol. 16, Issue 1
Published April 01, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (9)

L

Lisa A. De Stefano

H

Hyeonseok Kim

Wearable Intelligent Systems and Healthcare Center, Institute for Matter and Systems, Georgia Institute of Technology

C

Craig A. Erickson

E

Ernest V. Pedapati

K

Kelli C. Dominick

R

Rebecca Shaffer

L

Logan K. Wink

L

Lauren M. Schmitt

M

Makoto Miyakoshi